News
Ruxoprubart (NM8074) met all clinical endpoints, offering a safe, differentiated treatment for Paroxysmal Nocturnal ...
CLEVELAND, May 19, 2025 (GLOBE NEWSWIRE) -- NovelMed is pleased to announce positive 12-week interim results from the ongoing ...
Ruxoprubart is set to be developed as a novel treatment for several ... (aHUS), C3 Glomerulopathy (C3G), IgA Nephropathy (IgAN), ANCA-Associated Vasculitis (AAV), and Dermatomyositis (DM).
Fabhalta also recently showed encouraging top-line results in IgA nephropathy (IgAN), which ... and already approved for ANCA-associated vasculitis. Apellis’s injectable C3 inhibitor Empaveli ...
Panelists discuss how disease-modifying therapies for immunoglobulin A (IgA) nephropathy, though initially more expensive ...
Panelists discuss how early diagnosis of immunoglobulin A (IgA) nephropathy enables timely interventions that can ...
It is estimated that more than 5 million people worldwide suffer from ulcerative colitis, a chronic inflammation of the colon ...
Iga Swiatek has been a thorn in Coco Gauff's side throughout their careers. The rivals have played each other 15 times in their careers, despite being just 23 and 21 respectively, and it's the ...
However, the internet — and especially social media — as well as the COVID-19 pandemic seem to have drawn dubious treatments into the mainstream, according to Adam J. Brown, MD, of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results